Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Belley
Adam Belley, Beaconsfield CA
| Patent application number | Description | Published |
|---|---|---|
| 20110046041 | METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS - The present invention is directed to methods of inhibition, delay of formation, treatment, prophylaxis and/or prevention of infections caused by bacteria that exhibit tolerance to antimicrobial agents, including slow growing, stationary-phase and biofilm forming bacteria, through the use of glycopeptide antibiotics, such as oritavancin. | 02-24-2011 |
Germain Belley, Jonquiere CA
| Patent application number | Description | Published |
|---|---|---|
| 20090052988 | Asphalt recycling apparatus - An apparatus for recycling asphalt pieces obtained from the repairing work site, to repair rapidly potholes and cracks in roadway and at a minimum cost, and of which it is possible to produce a usable hot asphalt at a temperature about −12 to −15 degrees Celsius. | 02-26-2009 |
Michel Belley, Pierrefonds CA
| Patent application number | Description | Published |
|---|---|---|
| 20100022477 | FUSED AROMATIC PTP-1B INHIBITORS - The invention encompasses the novel class of compounds represented by the formula below, which are inhibitors of the PTP-1B enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown (Formula I) above and methods of treating or preventing PTP-1B mediated diseases, including diabetes. | 01-28-2010 |
| 20100179173 | SUBSTITUTED FUSED PYRIMIDINES AS ANTAGONISTS OF GPR105 ACTIVITY - Fused pyrimidine compounds of structural formula (I) are effective as antagonists of the biological activity of the GPR105 protein. They are useful for the treatment, control or prevention of disorders responsive to antagonism of this receptor, such as diabetes, particularly, Type 2 diabetes, insulin resistance, hyperglycemia, lipid disorders, obesity, atherosclerosis, and Metabolic Syndrome. | 07-15-2010 |
| 20100298347 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY - Substituted 2-naphthoic acids of structural formula are effective as antagonists of the biological activity of GPR105 protein. They are useful for the treatment, control or prevention of disorders responsive to antagonism of this receptor, such as diabetes, particularly, Type 2 diabetes, insulin resistance, hyperglycemia, lipid disorders, obesity, atherosclerosis, and conditions associated with the Metabolic Syndrome. | 11-25-2010 |
Michel Belley, Pierre Fonds CA
| Patent application number | Description | Published |
|---|---|---|
| 20090099226 | Quinoline derivatives as ep4 antagonists - The invention is directed to quinoline derivatives as prostaglandin E type receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. The derivatives have the following structure of formula (I): wherein A and B represents either a nitrogen atom or a CH group with the proviso that they cannot both simultaneously be CH, Q can represent a nitrogen or a carbon atom, and Y and Z are either a nitrogen atom, a N(O) group or a C(R | 04-16-2009 |
Pascal Belley, Quebec CA
| Patent application number | Description | Published |
|---|---|---|
| 20100218719 | PAINT ROLLER CAGE AND COVER - A roller painting kit comprising a roller cage adapter engageable over a roller section of a paint roller and having a substantially continuous cylindrical outer surface when engaged over the roller section, and a flexible roller cover insertable over the roller cage adapter, the roller cover being flexible so it can be rolled onto itself for storage. The roller cage adapter is radialy expandable to provide retention action between the roller cover and roller cage in an operative position. | 09-02-2010 |
Richard A. Belley, St. Louis, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20100146765 | IV Catheter with In-Line Valve and Methods Related Thereto - Featured is a vascular access device such as an IV catheter device including a housing, a tubular member and a seal member, and a securing mechanism. The housing includes a proximal and distal portion and a chamber that extends between the proximal and distal portions. The tubular member is coupled to the housing distal portion so it is fluidly coupled to the chamber. The seal member is disposed within the chamber and the securing mechanism secures the seal member distal end to the housing proximal portion so the seal member is sealingly and compressibly retained between a chamber proximal end and the securing mechanism. Such a seal member also is constituted so a portion of the seal member moves axially responsive to an axial force applied to the proximal end. | 06-17-2010 |